Banner Corporation Announces Fourth Quarter 2023 Conference Call and Webcast
WALLA WALLA, Wash., Dec. 29, 2023 (GLOBE NEWSWIRE) — Banner Corporation (NASDAQ GSM: BANR) (“Banner”), the parent company of Banner […]
Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
HAMILTON, BERMUDA, Dec. 29, 2023 (GLOBE NEWSWIRE) — HAMILTON, BERMUDA, Dec. 29, 2023 — Altamira Therapeutics Ltd. (“Altamira” or the […]
Tenax Therapeutics Announces Reverse Stock Split
CHAPEL HILL, N.C., Dec. 29, 2023 (GLOBE NEWSWIRE) — Tenax Therapeutics, Inc. (Nasdaq: TENX), a specialty pharmaceutical company focused on […]
Fortress Biotech Announces Pricing of $11 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
MIAMI, Dec. 29, 2023 (GLOBE NEWSWIRE) — Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress” or “Company”), an innovative biopharmaceutical company focused […]
Davis Commodities Limited Announces First Half of Fiscal Year 2023 Unaudited Financial Results
SINGAPORE, Dec. 29, 2023 (GLOBE NEWSWIRE) — Davis Commodities Limited (Nasdaq: DTCK) (the “Company” or “Davis Commodities”), an agricultural commodity […]
BullFrog AI Issues Letter to Shareholders
GAITHERSBURG, Md., Dec. 29, 2023 (GLOBE NEWSWIRE) — BullFrog AI Holdings, Inc. (NASDAQ: BFRG; BFRGW) (“BullFrog AI” or the “Company”), […]
STRATA Skin Sciences Announces Expansion of Distribution Agreement with Kosmo Meditech
HORSHAM, Pa., Dec. 29, 2023 (GLOBE NEWSWIRE) — STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical […]
Foresight Collaborates with One of the World’s Largest Electric Vehicle Brands
Parties sign collaboration agreement to evaluate Foresight’s 3D perceptioncapabilities for enhancing the manufacturer’s automotive vision solutions Ness Ziona, Israel, Dec. […]
VS Media Announces Receipt of Nasdaq Minimum Bid Price Notification
HONG KONG, Dec. 29, 2023 (GLOBE NEWSWIRE) — VS Media Holdings Limited (NASDAQ: VSME, the “Company”), a leader in managing […]
Chimerix Appoints Lisa Decker to Board of Directors
DURHAM, N.C., Dec. 29, 2023 (GLOBE NEWSWIRE) — Chimerix (NASDAQ:CMRX), a biopharmaceutical company whose mission is to develop medicines that […]
